FDA grants $23 million to boost research on rare diseases

04:22 EDT 19 Oct 2016 | Pharmafile

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, through their Orphan Products Clinical Trials Grants Program, will donate over $23 million to 21 clinical trials over the next four years. There were 68 grant applications for funding this year and the funding rate comes in at 31% of total applications.

read more

Original Article: FDA grants $23 million to boost research on rare diseases


More From BioPortfolio on "FDA grants $23 million to boost research on rare diseases"

Quick Search

Relevant Topics

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...